Fasiha Kanwal - Concepedia

Author

Fasiha Kanwal

Baylor College of Medicine ORCID

Also Known As

A Walling, F KANWAL, F Kanwal, F. KANWAL, F. Kanwal, Farhana Kanwal, Fasiha Kanwal, K. Lorenz, Oren Fix

403

Publications

22.8K

Citations

H-Index

151

Concepts

All Affiliations

Baylor College of Medicine Michael E. DeBakey VA Medical Center Center for Innovation Health Services Research & Development University of California, Los Angeles

About

Fasiha Kanwal is an author at Baylor College of Medicine specializing in medicine, hepatology, and epidemiology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Health Sciences	14	14	4.7K
2	Business	2	2	145
3	Engineering	2	2	233
4	Arts	1	1	12
5	Management	1	1	38

Fasiha Kanwal

124

Publications

13.6K

Citations

H-Index

Page 1

	Year	Citations
A multisociety Delphi consensus statement on new fatty liver disease nomenclature Mary E. Rinella, Jeffrey V. Lazarus, Vlad Ratziu, Hepatology Evidence-based MedicinePathologyFatty Liver DiseaseObesityMetabolic Syndrome	2023	2.5K
Risk of Hepatocellular Cancer in Patients With Non-Alcoholic Fatty Liver Disease Fasiha Kanwal, Jennifer R. Kramer, Srikar Mapakshi, Gastroenterology	2018	757
Hepatocellular Carcinoma in the Absence of Cirrhosis in United States Veterans Is Associated With Nonalcoholic Fatty Liver Disease Sahil Mittal, Hashem B. El‐Serag, Yvonne H. Sada, Clinical Gastroenterology and Hepatology Metabolic Associated SteatohepatitisHepatologyNonalcoholic Fatty Liver DiseaseHepatitisPathology	2015	627
Incidence of Hepatocellular Carcinoma in All 50 United States, From 2000 Through 2012 Donna L. White, Aaron P. Thrift, Fasiha Kanwal, Gastroenterology EpidemiologyHepatologyMedicineHistopathologyAll 50	2016	418
Reply: A multi-society Delphi consensus statement on new fatty liver disease nomenclature Jeffrey V. Lazarus, Philip N. Newsome, Sven Francque, Hepatology Jeffrey V.PathologyFatty Liver DiseaseHistorical ScholarshipObesity	2023	379
Effect of Metabolic Traits on the Risk of Cirrhosis and Hepatocellular Cancer in Nonalcoholic Fatty Liver Disease Fasiha Kanwal, Jennifer R. Kramer, Liang Li, Hepatology	2019	297
Long‐Term Risk of Hepatocellular Carcinoma in HCV Patients Treated With Direct Acting Antiviral Agents Fasiha Kanwal, Jennifer R. Kramer, Steven M. Asch, Hepatology	2019	267
Temporal Trends of Nonalcoholic Fatty Liver Disease–Related Hepatocellular Carcinoma in the Veteran Affairs Population Sahil Mittal, Yvonne H. Sada, Hashem B. El‐Serag, Clinical Gastroenterology and Hepatology HepatologyNonalcoholic Fatty Liver DiseaseTemporal TrendsLiver PhysiologyVeteran Affairs Population	2014	257
Metabolic dysfunction–associated steatotic liver disease: Update and impact of new nomenclature on the American Association for the Study of Liver Diseases practice guidance on nonalcoholic fatty liver disease Fasiha Kanwal, Brent A. Neuschwander‐Tetri, Rohit Loomba, Hepatology Metabolic DisorderSteatotic Liver DiseaseAmerican AssociationGastroenterologyPathology	2023	257
Houston Consensus Conference on Testing for Helicobacter pylori Infection in the United States Hashem B. El‐Serag, John Y. Kao, Fasiha Kanwal, Clinical Gastroenterology and Hepatology Helicobacter Pylori InfectionHouston Consensus ConferenceMedicineClinical EpidemiologyGastrointestinal Virus	2018	256

Page 1